Henning Schmidt

With over fourteen years of industry experience in Modeling and Simulation, mainly focusing on the areas of Pharmacometrics and Systems Pharmacology. During the last twelve years, he has provided decision-making support to drug discovery and development teams in various therapeutic areas, including oncology, dermatology, immunology, respiratory, bone and muscle wasting diseases. This has led to several go/no-go decisions on the progression of novel drugs through their development cycle and successful registrations. Henning greatly enjoys working in all stages of drug discovery and development, supporting project teams through integrative quantitative analyses, enabling informed decision making. In 2015 he founded IntiQuan GmbH and is building a strong Modeling and Simulation team, focusing on efficient high-quality support, ensuring compliance to regulatory requirements, including full reproducibility of analyses.

• Integration of available data to enable informed decision making
• Animal to human translation
• Dose finding
• Efficiency, Quality, Compliance, and Reproducibility

• Technische Hochschule Darmstadt, Germany
• Ecole Supérieure d’Electricité (SUPELEC), Paris, France
• Royal Institute of Technology, Stockholm, Sweden

• German
• Swedish
• English
• French